Clinical trial
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or…
NCT00053963 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00053963 |
|---|---|
| Title | FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia |
| Official title | A PHASE I STUDY OF DEPSIPEPTIDE (NSC#630176, IND# 51810) IN PEDIATRIC PATIENTS WITH REFRACTORY SOLID TUMORS AND LEUKEMIAS |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Blastic Phase Chronic Myelogenous Leukemia, Childhood Central Nervous System Germ Cell Tumor, Childhood Choroid Plexus Tumor, Childhood Chronic Myelogenous Leukemia, Childhood Craniopharyngioma, Childhood Grade I Meningioma, Childhood Grade II Meningioma, Childhood Grade III Meningioma, Childhood High-grade Cerebral Astrocytoma, Childhood Infratentorial Ependymoma and 16 more |
| Intervention type | Drug |
| Interventions | romidepsin |
| Enrollment | 30 |
| Start date | Sep 1, 2002 |
| Primary completion | Feb 1, 2006 |
| First posted | Feb 6, 2003 |
| Last update posted | Jan 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: